Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast Cancer

Diana Lüftner1, Hans-Christian Kolberg2, Andreas D Hartkopf3

  • 1Immanuel Hospital Märkische Schweiz, Buckow, Germany & Medical University of Brandenburg Theodor-Fontane, Rüdersdorf, Germany.

Insights

New therapies like CDK4/6 inhibitors and antibody-drug conjugates significantly improve survival for advanced breast cancer patients. This review covers recent advancements and promising treatments, offering hope for better outcomes.

Area of Science:

  • Oncology
  • Medical Therapeutics

Background:

  • Advanced stage breast cancer treatment has evolved significantly.
  • Conventional chemotherapy is being replaced by targeted therapies and immunotherapies.

Purpose of the Study:

  • To review recent advancements in the treatment of advanced stage breast cancer.
  • To summarize key findings from recent publications and conference presentations.

Main Methods:

  • Literature review of recent publications.
  • Analysis of conference presentations on breast cancer treatment.

Main Results:

  • CDK4/6 inhibitors, trastuzumab deruxtecan, and sacituzumab govitecan demonstrate significant overall survival benefits.
  • New PI3K/AKT-kinase inhibitors, SERDs, antibody-drug conjugates, immune therapies, and PARP inhibitors are emerging as promising treatments.

Conclusions:

  • The therapeutic landscape for advanced breast cancer is rapidly changing with novel agents.
  • Ongoing research and rapid study execution promise further improvements in patient survival.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310